Treatment.com AI Inc.
TRUE
CNSX
| 03/31/2024 | 09/30/2023 | 06/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -97.99% | -97.49% | -97.28% | -66.65% |
| Gross Profit | -- | 103.54% | 97.49% | 97.28% | 66.65% |
| SG&A Expenses | -- | -71.04% | -84.73% | -84.80% | -86.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -76.28% | -87.09% | -87.18% | -85.83% |
| Operating Income | -- | 76.67% | 87.09% | 87.18% | 85.83% |
| Income Before Tax | -- | 75.83% | 86.33% | 86.40% | 85.17% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | 75.83% | 86.33% | 86.40% | 85.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 75.83% | 86.33% | 86.40% | 85.17% |
| EBIT | -- | 76.67% | 87.09% | 87.18% | 85.83% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | 76.24% | 86.50% | 86.58% | 85.41% |
| Normalized Basic EPS | -- | 76.27% | 86.63% | 86.71% | 85.52% |
| EPS Diluted | -- | 76.24% | 86.50% | 86.58% | 85.41% |
| Normalized Diluted EPS | -- | 76.27% | 86.63% | 86.71% | 85.52% |
| Average Basic Shares Outstanding | -- | 1.31% | 0.97% | 0.98% | 1.63% |
| Average Diluted Shares Outstanding | -- | 1.31% | 0.97% | 0.98% | 1.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
